Expands collaborative drug therapy management by pharmacists; makes permanent certain provisions relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings.
- Chamber
- House
- Introduced
- May 11, 2026
- Last action
- May 11, 2026 — REFERRED TO HIGHER EDUCATION
- Session
- 2025-2026
- Momentum
- 28 · Low